Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide for Alzheimer's Disease
NCT00580931Phase 2Completed
- Sponsor
- University of California, Irvine
- Start
- Jan 2008
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotinamide in Alzheimer's disease (AD), sponsored by University of California, Irvine. Started Jan 2008; status: completed.
02
Drugs
nicotinamide
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00580931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00580931.